Frederico G. F. L. R. Gomes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Frederico G. F. L. R. Gomes has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Andressa Duarte
Department of Pathology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14040-900, São Paulo, Brazil
1 shared publication - Antonio Claudio Tedesco
Department of Chemistry Center of Nanotechnology and Tissue Engineering Photobiology and Photomedicine Research Group Faculty of Philosophy, Sciences, and Letters of Ribeirão Preto University of São Paulo Ribeirão Preto Brazil
1 shared publication - Bruna Amanda Cruz Rattis
Fiocruz-Bi-Institutional Translational Medicine Plataform, Ribeirão Preto, SP, 14049-900, Brazil
1 shared publication - Danilo Figueiredo Soave
Department of Pathology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil
1 shared publication - Henrique Luis Piva
Department of Chemistry‐ FFCLRP Center of Nanotechnology and Tissue Engineering ‐ CNET University of São Paulo Ribeirão Preto São Paulo 14040‐901 Brazil
1 shared publication - Janaína R. Lellis
Department of Pathology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14040-900, São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 24 October 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (11) , 2277
Modulation of the mTOR Pathway by Curcumin in the Heart of Septic Mice
MTOR is a signaling pathway involved in cell survival, cell stress response, and protein synthesis that may be a key point in sepsis-induced cardiac dysfunction. Curcumin has been reported in vitro as an mTOR inhibitor compound; however, there are no studies demonstrating this effect in experimental sepsis. Thus, this study aimed to evaluate the action of curcumin on the mTOR pathway in the heart of septic mice. Free curcumin (FC) and nanocurcumin (NC) were used, and samples were obtained at 24 and 120 h after sepsis. Histopathological and ultrastructural analysis showed that treatments with FC and NC reduced cardiac lesions caused by sepsis. Our main results demonstrated that curcumin reduced mTORC1 and Raptor mRNA at 24 and 120 h compared with the septic group; in contrast, mTORC2 mRNA increased at 24 h. Additionally, the total mTOR mRNA expression was reduced at 24 h compared with the septic group. Our results indicate that treatment with curcumin and nanocurcumin promoted a cardioprotective response that could be related to the modulation of the mTOR pathway.
- 24 October 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (11) , 2277
Open AccessModulation of the mTOR Pathway by Curcumin in the Heart of Septic Mice
MTOR is a signaling pathway involved in cell survival, cell stress response, and protein synthesis that may be a key point in sepsis-induced cardiac dysfunction. Curcumin has been reported in vitro as an mTOR inhibitor compound; however, there are no studies demonstrating this effect in experimental sepsis. Thus, this study aimed to evaluate the action of curcumin on the mTOR pathway in the heart of septic mice. Free curcumin (FC) and nanocurcumin (NC) were used, and samples were obtained at 24 and 120 h after sepsis. Histopathological and ultrastructural analysis showed that treatments with FC and NC reduced cardiac lesions caused by sepsis. Our main results demonstrated that curcumin reduced mTORC1 and Raptor mRNA at 24 and 120 h compared with the septic group; in contrast, mTORC2 mRNA increased at 24 h. Additionally, the total mTOR mRNA expression was reduced at 24 h compared with the septic group. Our results indicate that treatment with curcumin and nanocurcumin promoted a cardioprotective response that could be related to the modulation of the mTOR pathway.